NEXGARD — Canadian market authorization (DIN)
Source: Health Canada Drug Product Database (DPD) — first-hand veterinary drug registration extract (dpd_pet_antiparasitic_all.csv). This topic records the Canadian market authorization (Drug Identification Number, DIN) for this product. The verbatim registration record is reproduced below. Indications, contraindications and dosing are defined in the product monograph / label, which is not part of the DPD summary extract and is marked pending (requires the product monograph / FDA Green Book FOI summary for full label depth).
Verbatim DPD registration record
Marketed,02427435,Dogs,BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.,NEXGARD,Veterinary,Yes,PRESCRIPTION,1,AFOXOLANER,11.3 MG
Field guide
- Status: Marketed
- DIN: 02427435
- Species: Dogs
- Company: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
- Product: NEXGARD
- Class: Veterinary
- Prescription: PRESCRIPTION
- Active ingredient(s): AFOXOLANER
- Strength: 11.3 MG
- Therapeutic class (annotation): ectoparasiticide (oral)
Source file: /home/cai/notes/knowledge/side-projects/petfood-data-station/pdf-raw/ca-2026/dpd/dpd_pet_antiparasitic_all.csv